BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang Q, Su R, Shan C, Gao C, Wu P. Non-SMC Condensin I Complex, Subunit G (NCAPG) is a Novel Mitotic Gene Required for Hepatocellular Cancer Cell Proliferation and Migration. Oncol Res. 2018;26:269-276. [PMID: 29046167 DOI: 10.3727/096504017x15075967560980] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Schiklenk C, Petrova B, Kschonsak M, Hassler M, Klein C, Gibson TJ, Haering CH. Control of mitotic chromosome condensation by the fission yeast transcription factor Zas1. J Cell Biol 2018;217:2383-401. [PMID: 29735745 DOI: 10.1083/jcb.201711097] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
2 Ghatnatti V, Vastrad B, Patil S, Vastrad C, Kotturshetti I. Identification of potential and novel target genes in pituitary prolactinoma by bioinformatics analysis. AIMS Neurosci 2021;8:254-83. [PMID: 33709028 DOI: 10.3934/Neuroscience.2021014] [Reference Citation Analysis]
3 Jiang X, Shi Y, Chen X, Xu H, Liu B, Zhou F, Huang X, Cho WC, Li L, Pu J. NCAPG as a Novel Prognostic Biomarker in Glioma. Front Oncol 2022;12:831438. [PMID: 35280743 DOI: 10.3389/fonc.2022.831438] [Reference Citation Analysis]
4 Kim JH, Youn Y, Kim KT, Jang G, Hwang JH. Non-SMC condensin I complex subunit H mediates mature chromosome condensation and DNA damage in pancreatic cancer cells. Sci Rep 2019;9:17889. [PMID: 31784646 DOI: 10.1038/s41598-019-54478-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
5 Li Z, Sang M, Tian Z, Liu Z, Lv J, Zhang F, Shan B. Identification of key biomarkers and potential molecular mechanisms in lung cancer by bioinformatics analysis. Oncol Lett 2019;18:4429-40. [PMID: 31611952 DOI: 10.3892/ol.2019.10796] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
6 Yang L, Yin W, Liu X, Li F, Ma L, Wang D, Li H. Identification of a five-gene signature in association with overall survival for hepatocellular carcinoma. PeerJ 2021;9:e11273. [PMID: 33986994 DOI: 10.7717/peerj.11273] [Reference Citation Analysis]
7 Li S, Xuan Y, Gao B, Sun X, Miao S, Lu T, Wang Y, Jiao W. Identification of an eight-gene prognostic signature for lung adenocarcinoma. Cancer Manag Res 2018;10:3383-92. [PMID: 30237740 DOI: 10.2147/CMAR.S173941] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 6.5] [Reference Citation Analysis]
8 Bian J, Xu Y, Wu F, Pan Q, Liu Y. Identification of a five-gene signature for predicting the progression and prognosis of stage I endometrial carcinoma. Oncol Lett 2020;20:2396-410. [PMID: 32782557 DOI: 10.3892/ol.2020.11798] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
9 Dong M, Xu T, Cui X, Li H, Li X, Xia W. NCAPG upregulation mediated by four microRNAs combined with activation of the p53 signaling pathway is a predictor of poor prognosis in patients with breast cancer. Oncol Lett 2021;21:323. [PMID: 33692855 DOI: 10.3892/ol.2021.12585] [Reference Citation Analysis]
10 Huang C, Hu CG, Ning ZK, Huang J, Zhu ZM. Identification of key genes controlling cancer stem cell characteristics in gastric cancer. World J Gastrointest Surg 2020; 12(11): 442-459 [PMID: 33304447 DOI: 10.4240/wjgs.v12.i11.442] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
11 Wang F, Breslin S J P, Qiu W. Novel oncogenes and tumor suppressor genes in hepatocellular carcinoma. Liver Res 2021;5:195-203. [PMID: 34900376 DOI: 10.1016/j.livres.2021.06.001] [Reference Citation Analysis]
12 Wu P, Xiao Y, Guo T, Wang Y, Liao S, Chen L, Liu Z. Identifying miRNA-mRNA Pairs and Novel miRNAs from Hepatocelluar Carcinoma miRNomes and TCGA Database. J Cancer. 2019;10:2552-2559. [PMID: 31258761 DOI: 10.7150/jca.28167] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
13 Zhou Y, Fan Y, Mao Y, Lou M, Liu X, Yuan K, Tong J. NCAPG is a prognostic biomarker of immune infiltration in non-small-cell lung cancer. Biomark Med 2022. [PMID: 35199566 DOI: 10.2217/bmm-2021-1090] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
14 Sun DP, Lin CC, Hung ST, Kuang YY, Hseu YC, Fang CL, Lin KY. Aberrant Expression of NCAPG is Associated with Prognosis and Progression of Gastric Cancer. Cancer Manag Res 2020;12:7837-46. [PMID: 32922082 DOI: 10.2147/CMAR.S248318] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Wang HZ, Yang SH, Li GY, Cao X. Subunits of human condensins are potential therapeutic targets for cancers. Cell Div 2018;13:2. [PMID: 29467813 DOI: 10.1186/s13008-018-0035-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
16 Ai J, Gong C, Wu J, Gao J, Liu W, Liao W, Wu L. MicroRNA‑181c suppresses growth and metastasis of hepatocellular carcinoma by modulating NCAPG. Cancer Manag Res 2019;11:3455-67. [PMID: 31114379 DOI: 10.2147/CMAR.S197716] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
17 Liu J, Feng M, Li S, Nie S, Wang H, Wu S, Qiu J, Zhang J, Cheng W. Identification of molecular markers associated with the progression and prognosis of endometrial cancer: a bioinformatic study. Cancer Cell Int 2020;20:59. [PMID: 32099532 DOI: 10.1186/s12935-020-1140-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
18 Wang Y, Wang J, Yan K, Lin J, Zheng Z, Bi J. Identification of core genes associated with prostate cancer progression and outcome via bioinformatics analysis in multiple databases. PeerJ 2020;8:e8786. [PMID: 32266115 DOI: 10.7717/peerj.8786] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
19 Song X, Du R, Gui H, Zhou M, Zhong W, Mao C, Ma J. Identification of potential hub genes related to the progression and prognosis of hepatocellular carcinoma through integrated bioinformatics analysis. Oncol Rep 2020;43:133-46. [PMID: 31746405 DOI: 10.3892/or.2019.7400] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
20 Xiao X, Zhang Z, Luo R, Peng R, Sun Y, Wang J, Chen X. Identification of potential oncogenes in triple-negative breast cancer based on bioinformatics analyses. Oncol Lett 2021;21:363. [PMID: 33747220 DOI: 10.3892/ol.2021.12624] [Reference Citation Analysis]
21 Ho C, Lin K, Shen R, Gu D, Lee S, Su W, Jou Y. Prognostic comparative genes predict targets for sorafenib combination therapies in hepatocellular carcinoma. Computational and Structural Biotechnology Journal 2022. [DOI: 10.1016/j.csbj.2022.04.008] [Reference Citation Analysis]
22 Shi Z, Xiao Z, Hu L, Gao Y, Zhao J, Liu Y, Shen G, Xu Q, Huang D. The genetic association between type 2 diabetic and hepatocellular carcinomas. Ann Transl Med 2020;8:380. [PMID: 32355824 DOI: 10.21037/atm.2020.02.13] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
23 Gu Y, Li J, Guo D, Chen B, Liu P, Xiao Y, Yang K, Liu Z, Liu Q. Identification of 13 Key Genes Correlated With Progression and Prognosis in Hepatocellular Carcinoma by Weighted Gene Co-expression Network Analysis. Front Genet 2020;11:153. [PMID: 32180800 DOI: 10.3389/fgene.2020.00153] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
24 Yang Z, Wu X, Li J, Zheng Q, Niu J, Li S. CCNB2, CDC20, AURKA, TOP2A, MELK, NCAPG, KIF20A, UBE2C, PRC1, and ASPM May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis. Int J Gen Med 2021;14:10185-94. [PMID: 34992437 DOI: 10.2147/IJGM.S341379] [Reference Citation Analysis]
25 Li H, Zheng P, Li Z, Han Q, Zhou B, Wang X, Wang K, Theocharis SE. NCAPG Promotes the Proliferation of Renal Clear Cell Carcinoma via Mediating with CDK1. Disease Markers 2022;2022:1-12. [DOI: 10.1155/2022/6758595] [Reference Citation Analysis]
26 Qi Y, Mo K, Zhang T. A transcription factor that promotes proliferation, migration, invasion, and epithelial-mesenchymal transition of ovarian cancer cells and its possible mechanisms. Biomed Eng Online 2021;20:83. [PMID: 34399777 DOI: 10.1186/s12938-021-00919-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Yamamoto S, Takayama KI, Obinata D, Fujiwara K, Ashikari D, Takahashi S, Inoue S. Identification of new octamer transcription factor 1-target genes upregulated in castration-resistant prostate cancer. Cancer Sci 2019;110:3476-85. [PMID: 31454442 DOI: 10.1111/cas.14183] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
28 Sun C, Huang S, Wang H, Xie R, Zhang L, Zhou Q, He X, Ju W. Non-SMC condensin I complex subunit H enhances proliferation, migration, and invasion of hepatocellular carcinoma. Mol Carcinog 2019;58:2266-75. [PMID: 31523845 DOI: 10.1002/mc.23114] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
29 Morovat P, Morovat S, Ashrafi AM, Teimourian S. Identification of potentially functional circular RNAs hsa_circ_0070934 and hsa_circ_0004315 as prognostic factors of hepatocellular carcinoma by integrated bioinformatics analysis. Sci Rep 2022;12:4933. [PMID: 35322101 DOI: 10.1038/s41598-022-08867-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Wang Y, Gao B, Tan PY, Handoko YA, Sekar K, Deivasigamani A, Seshachalam VP, OuYang HY, Shi M, Xie C, Goh BKP, Ooi LL, Man Hui K. Genome-wide CRISPR knockout screens identify NCAPG as an essential oncogene for hepatocellular carcinoma tumor growth. FASEB J 2019;33:8759-70. [PMID: 31022357 DOI: 10.1096/fj.201802213RR] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 7.3] [Reference Citation Analysis]
31 Xu T, Dong M, Wang Z, Li H, Li X. Elevated mRNA Expression Levels of NCAPG are Associated with Poor Prognosis in Ovarian Cancer. Cancer Manag Res 2020;12:5773-86. [PMID: 32765080 DOI: 10.2147/CMAR.S253349] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
32 Jiang L, Ren L, Chen H, Pan J, Zhang Z, Kuang X, Chen X, Bao W, Lin C, Zhou Z, Huang D, Yang J, Huang H, Wang L, Hou N, Song L. NCAPG confers trastuzumab resistance via activating SRC/STAT3 signaling pathway in HER2-positive breast cancer. Cell Death Dis 2020;11:547. [PMID: 32683421 DOI: 10.1038/s41419-020-02753-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
33 Song B, Du J, Song DF, Ren JC, Feng Y. Dysregulation of NCAPG, KNL1, miR-148a-3p, miR-193b-3p, and miR-1179 may contribute to the progression of gastric cancer. Biol Res 2018;51:44. [PMID: 30390708 DOI: 10.1186/s40659-018-0192-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
34 Gong C, Ai J, Fan Y, Gao J, Liu W, Feng Q, Liao W, Wu L. NCAPG Promotes The Proliferation Of Hepatocellular Carcinoma Through PI3K/AKT Signaling. Onco Targets Ther 2019;12:8537-52. [PMID: 31802891 DOI: 10.2147/OTT.S217916] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 7.7] [Reference Citation Analysis]
35 Zhang X, Wang H, Han Y, Zhu M, Song Z, Zhan D, Jia J. NCAPG Induces Cell Proliferation in Cardia Adenocarcinoma via PI3K/AKT Signaling Pathway. Onco Targets Ther 2020;13:11315-26. [PMID: 33177839 DOI: 10.2147/OTT.S276868] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
36 Cui F, Hu J, Xu Z, Tan J, Tang H. Overexpression of NCAPH is upregulated and predicts a poor prognosis in prostate cancer. Oncol Lett 2019;17:5768-76. [PMID: 31186803 DOI: 10.3892/ol.2019.10260] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
37 Alshabi AM, Shaikh IA, Vastrad C; BasavarajVastrad. Exploring the Molecular Mechanism of the Drug-Treated Breast Cancer Based on Gene Expression Microarray. Biomolecules 2019;9:E282. [PMID: 31311202 DOI: 10.3390/biom9070282] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
38 Shimomura H, Sasahira T, Nakashima C, Kurihara-Shimomura M, Kirita T. Non-SMC Condensin I Complex Subunit H (NCAPH) Is Associated with Lymphangiogenesis and Drug Resistance in Oral Squamous Cell Carcinoma. J Clin Med 2019;9:E72. [PMID: 31892156 DOI: 10.3390/jcm9010072] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]